Evidence map›Paper›PMID 40277096›Full record

ArticleJournal of clinical periodontology2025

The Synergetic Effect of Periodontal Therapy and TNF-α Inhibitor for the Treatment of Comorbid Periodontitis and Psoriasis.

Crystal Marruganti, Carlo Gaeta, Chiara Falciani, Elisa Cinotti, Pietro Rubegni, Mario Alovisi, Nicola Scotti, Andrea Baldi, Cristiana Bellan, Chiara Defraia and 8 more

Abstract read
In one paragraph

Article in Journal of clinical periodontology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Crystal MarrugantiUnit of Periodontology, Endodontology and Restorative Dentistry, Department of Medical Biotechnologies, University of Siena, Siena, Italy.ORCID 0000-0003-1088-2046
Carlo GaetaUnit of Periodontology, Endodontology and Restorative Dentistry, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Chiara FalcianiDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Elisa CinottiUnit of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy.
Pietro RubegniUnit of Dermatology, Department of Medical, Surgical and Neurological Science, University of Siena, Siena, Italy.
Mario AlovisiDepartment of Surgical Sciences, C.I.R. Dental School, University of Turin, Turin, Italy.
Nicola ScottiDepartment of Surgical Sciences, C.I.R. Dental School, University of Turin, Turin, Italy.
Andrea BaldiDepartment of Surgical Sciences, C.I.R. Dental School, University of Turin, Turin, Italy.
Cristiana BellanUnit of Anatomical Pathology, Department of Human Pathology and Oncology, University of Siena, Siena, Italy.
Chiara DefraiaUnit of Anatomical Pathology, Department of Human Pathology and Oncology, University of Siena, Siena, Italy.
Elena BertaggiaUnit of Anatomical Pathology, Department of Human Pathology and Oncology, University of Siena, Siena, Italy.
Fabio FiorinoLaboratory of Molecular Microbiology and Biotechnology (LAMMB), Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Silvia ValensinFondazione Toscana Life Sciences, Siena, Italy.
Erika BelliniFondazione Toscana Life Sciences, Siena, Italy.
Antonella De RosaFondazione Toscana Life Sciences, Siena, Italy.
Filippo GrazianiDepartment of Surgery, Unit of Dentistry and Oral Surgery, University of Pisa, Pisa, Italy.ORCID 0000-0001-8780-7306
Francesco D'AiutoPeriodontology Unit, UCL Eastman Dental Institute and Hospital, University College London, London, UK.ORCID 0000-0001-8654-935X
Simone GrandiniUnit of Periodontology, Endodontology and Restorative Dentistry, Department of Medical Biotechnologies, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the adjunctive effect of periodontal therapy on psoriasis-related outcomes in a combined experimental model of ligature-induced periodontitis and Imiquimod (IMQ)-induced psoriasis. Also, this experiment aimed to study the impact of TNF-α inhibitors on the periodontium.

methodsFifty-six C57/BL6J mice were randomly allocated to seven experimental groups: (a) control group (P-Pso-) with no treatment; (b) periodontitis (P+Pso-) with periodontal therapy; (c) periodontitis (P+Pso-) with TNF-α inhibitor; (d) psoriasis (P-Pso+) with TNF-α inhibitor; (e) periodontitis and psoriasis (P+Pso+) with periodontal therapy; (f) P+Pso+ with TNF-α inhibitor; and (g) P+Pso+ with both periodontal therapy and TNF-α inhibitor. Samples (maxilla, dorsal skin and blood) were harvested immediately after death. Measures of periodontitis distance between the cemento-enamel junction and alveolar bone crest (CEJ-ABC) and number of osteoclasts and psoriasis (epidermal thickness and infiltrate cells (per 0.03mm

resultsIn the P+Pso+ group, a significant adjunctive effect of periodontal therapy to TNF-α inhibitors was found in the reduction of epidermal thickening and inflammatory infiltrate of the dorsal skin (p < 0.05). Similarly, treatment with TNF-α inhibitor resulted in a significant adjunctive effect to periodontal therapy in the reduction of alveolar bone loss (p < 0.05). These changes were accompanied by a significant decrease in the circulating levels of IL-6 and IL-17A when both periodontal therapy and TNF-α inhibitor were administered.

conclusionsThe combination of periodontal therapy and TNF-α inhibitor showed a positive synergetic effect in the treatment of comorbid experimental ligature-induced periodontitis and IMQ-induced psoriasis via the reduction of systemic inflammation.

Indexed as

PeriodontitisPsoriasisTumor Necrosis Factor-alphaAnimalsCombined Modality TherapyDisease Models, AnimalImiquimodInterleukin-17Interleukin-6MaleMiceMice, Inbred C57BLRandom AllocationImiquimodInterleukin-17Interleukin-6Tumor Necrosis Factor-alphaBiologicsperiodontal diseasesperiodontal therapypsoriasisskin diseases

Identifiers

PMID40277096
PMCPMC12082780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.